These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus. Simons WR, Hagan MA. Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756 [Abstract] [Full Text] [Related]
4. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects. Bays HE, Goldberg RB, Truitt KE, Jones MR. Arch Intern Med; 2008 Oct 13; 168(18):1975-83. PubMed ID: 18852398 [Abstract] [Full Text] [Related]
6. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy. Fonseca VA, Rosenstock J, Wang AC, Truitt KE, Jones MR. Diabetes Care; 2008 Aug 13; 31(8):1479-84. PubMed ID: 18458145 [Abstract] [Full Text] [Related]
8. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes. Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL. Clin Ther; 2007 Jan 13; 29(1):74-83. PubMed ID: 17379048 [Abstract] [Full Text] [Related]
9. Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes. Rosenson RS, Abby SL, Jones MR. Atherosclerosis; 2009 Jun 13; 204(2):342-4. PubMed ID: 18996525 [Abstract] [Full Text] [Related]
10. The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetes. Rosenstock J, Rigby SP, Ford DM, Tao B, Chou HS. Horm Metab Res; 2014 May 13; 46(5):348-53. PubMed ID: 24356792 [Abstract] [Full Text] [Related]
11. Safety and efficacy of colesevelam HCl in the treatment of elderly patients. Gavin JR, Jones MR, Ford DM, Truitt KE. Drugs Aging; 2014 Jun 13; 31(6):461-70. PubMed ID: 24777691 [Abstract] [Full Text] [Related]
12. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study. Handelsman Y, Goldberg RB, Garvey WT, Fonseca VA, Rosenstock J, Jones MR, Lai YL, Jin X, Misir S, Nagendran S, Abby SL. Endocr Pract; 2010 Jun 13; 16(4):617-28. PubMed ID: 20634176 [Abstract] [Full Text] [Related]
15. Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus. Henry RR, Aroda VR, Mudaliar S, Garvey WT, Chou HS, Jones MR. Diabetes Obes Metab; 2012 Jan 13; 14(1):40-6. PubMed ID: 21831167 [Abstract] [Full Text] [Related]
16. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial. Huijgen R, Abbink EJ, Bruckert E, Stalenhoef AF, Imholz BP, Durrington PN, Trip MD, Eriksson M, Visseren FL, Schaefer JR, Kastelein JJ, Triple Study Group. Clin Ther; 2010 Apr 13; 32(4):615-25. PubMed ID: 20435231 [Abstract] [Full Text] [Related]
19. Colesevelam: a new and improved bile acid sequestrant? Tziomalos K, Karagiannis A, Mikhailidis DP, Athyros VG. Curr Pharm Des; 2013 Apr 13; 19(17):3115-23. PubMed ID: 23317402 [Abstract] [Full Text] [Related]
20. Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes. Rosenstock J, Hernandez-Triana E, Handelsman Y, Misir S, Jones MR. Postgrad Med; 2012 Jul 13; 124(4):14-20. PubMed ID: 22913890 [Abstract] [Full Text] [Related] Page: [Next] [New Search]